Reactive oxygen species derived from NADPH oxidase 1 and mitochondria mediate angiotensin II-induced smooth muscle cell senescence

Journal of Molecular and Cellular Cardiology

Volumn 98, Issue , 2016, Pages 18-27

  Tsai, I Ching ^a,b   Pan, Zih cian ^a   Cheng, Hui Pin ^a   Liu, Chen Hsiu ^a   Lin, Bor Tyng ^a   Jiang, Meei Jyh ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Angiotensin II; Cellular senescence; Mitochondria; NADPH oxidase 1; Reactive oxygen species; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN II; BETA GALACTOSIDASE; CATALASE; ISOENZYME; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN P16; PROTEIN P21; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SMALL INTERFERING RNA; UNCOUPLING PROTEIN 2; NOX1 PROTEIN, HUMAN; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; CELL AGING; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE DEPOLARIZATION; MITOCHONDRION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE CELL; CELL CULTURE; DRUG EFFECTS; GENE SILENCING; GENETICS; METABOLISM; MUSCLE MITOCHONDRION; OXIDATION REDUCTION REACTION; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; CATALASE; CELL AGING; CELLS, CULTURED; GENE KNOCKDOWN TECHNIQUES; HUMANS; MITOCHONDRIA, MUSCLE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR 1-ALPHA; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; UNCOUPLING PROTEIN 2;

EID: 84978816860     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2016.07.001     Document Type: Article

References (45)

1. [1] Lakatta, E.G., Levy, D., Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a “set up” for vascular disease. Circulation 107 (2003), 139–146.
2. [2] Hayflick, L., Current theories of biological aging. Fed. Proc. 34 (1975), 9–13.
3. [3] Schneider, E.L., Mitsui, Y., The relationship between in vitro cellular aging and in vivo human age. Proc. Natl. Acad. Sci. U. S. A. 73 (1976), 3584–3588.
4. [4] Thompson, K.V., Holliday, R., Genetic effects on the longevity of cultured human fibroblasts. II. DNA repair deficient syndromes. Gerontology 29 (1983), 83–88.
5. [5] Dimri, G.P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U. S. A. 92 (1995), 9363–9367.
6. [6] Campisi, J., di Fagagna, F.D.A., Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8 (2007), 729–740.
7. [7] Chen, Q.M., Bartholomew, J.C., Campisi, J., Acosta, M., Reagan, J.D., Ames, B.N., Molecular analysis of H2O2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication. Biochem. J. 332:Pt 1 (1998), 43–50.
8. [8] Finkel, T., Holbrook, N.J., Oxidants, oxidative stress and the biology of ageing. Nature 408 (2000), 239–247.
9. [9] Bedard, K., Krause, K.H., The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87 (2007), 245–313.
10. [10] Schiffrin, E.L., Park, J.B., Intengan, H.D., Touyz, R.M., Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 101 (2000), 1653–1659.
11. [11] Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R., Dagenais, G., Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators, N Engl J Med. 342 (2000), 145–153.
12. [12] Najjar, S.S., Scuteri, A., Lakatta, E.G., Arterial aging: is it an immutable cardiovascular risk factor?. Hypertension 46 (2005), 454–462.
13. [13] Mehta, P.K., Griendling, K.K., Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am. J. Phys. Cell Physiol. 292 (2007), C82–C97.
14. [14] Herbert, K.E., Mistry, Y., Hastings, R., Poolman, T., Niklason, L., Williams, B., Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways. Circ. Res. 102 (2008), 201–208.
15. [15] Min, L.J., Mogi, M., Iwanami, J., Li, J.M., Sakata, A., Fujita, T., et al. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence. Cardiovasc. Res. 76 (2007), 506–516.
16. [16] Kunieda, T., Minamino, T., Nishi, J., Tateno, K., Oyama, T., Katsuno, T., et al. Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway. Circulation 114 (2006), 953–960.
17. [17] Mistry, Y., Poolman, T., Williams, B., Herbert, K.E., A role for mitochondrial oxidants in stress-induced premature senescence of human vascular smooth muscle cells. Redox Biol. 1 (2013), 411–417.
18. [18] Doughan, A.K., Harrison, D.G., Dikalov, S.I., Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ. Res. 102 (2008), 488–496.
19. [19] Lassegue, B., Sorescu, D., Szocs, K., Yin, Q., Akers, M., Zhang, Y., et al. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ. Res. 88 (2001), 888–894.
20. [20] Griendling, K.K., Minieri, C.A., Ollerenshaw, J.D., Alexander, R.W., Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74 (1994), 1141–1148.
21. [21] Benigni, A., Corna, D., Zoja, C., Sonzogni, A., Latini, R., Salio, M., et al. Disruption of the Ang II type 1 receptor promotes longevity in mice. J. Clin. Invest. 119 (2009), 524–530.
22. [22] St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J.M., Rhee, J., Jager, S., et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127 (2006), 397–408.
23. [23] Rajagopalan, S., Kurz, S., Munzel, T., Tarpey, M., Freeman, B.A., Griendling, K.K., et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97 (1996), 1916–1923.
24. [24] Salmon, A.B., Richardson, A., Perez, V.I., Update on the oxidative stress theory of aging: does oxidative stress play a role in aging or healthy aging?. Free Radic. Biol. Med. 48 (2010), 642–655.
25. [25] Brown, D.I., Griendling, K.K., Regulation of signal transduction by reactive oxygen species in the cardiovascular system. Circ. Res. 116 (2015), 531–549.
26. [26] Jones, D.P., Go, Y.M., Redox compartmentalization and cellular stress. Diabetes, Obesity & Metabolism 12:Suppl. 2 (2010), 116–125.
27. [27] Dikalov, S.I., Dikalova, A.E., Bikineyeva, A.T., Schmidt, H.H., Harrison, D.G., Griendling, K.K., Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic. Biol. Med. 45 (2008), 1340–1351.
28. [28] Higashi, M., Shimokawa, H., Hattori, T., Hiroki, J., Mukai, Y., Morikawa, K., et al. Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ. Res. 93 (2003), 767–775.
29. [29] Wingler, K., Wunsch, S., Kreutz, R., Rothermund, L., Paul, M., Schmidt, H.H., Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic. Biol. Med. 31 (2001), 1456–1464.
30. [30] Oudot, A., Martin, C., Busseuil, D., Vergely, C., Demaison, L., Rochette, L., NADPH oxidases are in part responsible for increased cardiovascular superoxide production during aging. Free Radic. Biol. Med. 40 (2006), 2214–2222.
31. [31] Matsuno, K., Yamada, H., Iwata, K., Jin, D., Katsuyama, M., Matsuki, M., et al. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 112 (2005), 2677–2685.
32. [32] Lee, M.Y., San Martin, A., Mehta, P.K., Dikalova, A.E., Garrido, A.M., Datla, S.R., et al. Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arterioscler. Thromb. Vasc. Biol. 29 (2009), 480–487.
33. [33] Ballinger, S.W., Mitochondrial dysfunction in cardiovascular disease. Free Radic. Biol. Med. 38 (2005), 1278–1295.
34. [34] Ungvari, Z., Sonntag, W.E., Csiszar, A., Mitochondria and aging in the vascular system. J Mol Med (Berl) 88 (2010), 1021–1027.
35. [35] Schriner, S.E., Linford, N.J., Martin, G.M., Treuting, P., Ogburn, C.E., Emond, M., et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308 (2005), 1909–1911.
36. [36] Zhou, R., Yazdi, A.S., Menu, P., Tschopp, J., A role for mitochondria in NLRP3 inflammasome activation. Nature 469 (2011), 221–225.
37. [37] Ungvari, Z., Orosz, Z., Labinskyy, N., Rivera, A., Xiangmin, Z., Smith, K., et al. Increased mitochondrial H2O2 production promotes endothelial NF-kappaB activation in aged rat arteries. Am. J. Physiol. Heart Circ. Physiol. 293 (2007), H37–H47.
38. [38] Lopez-Lluch, G., Hunt, N., Jones, B., Zhu, M., Jamieson, H., Hilmer, S., et al. Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 1768–1773.
39. [39] Ungvari, Z., Labinskyy, N., Gupte, S., Chander, P.N., Edwards, J.G., Csiszar, A., Dysregulation of mitochondrial biogenesis in vascular endothelial and smooth muscle cells of aged rats. Am. J. Physiol. Heart Circ. Physiol. 294 (2008), H2121–H2128.
40. [40] Kroller-Schon, S., Jansen, T., Schuler, A., Oelze, M., Wenzel, P., Hausding, M., et al. Peroxisome proliferator-activated receptor gamma, coactivator 1alpha deletion induces angiotensin II-associated vascular dysfunction by increasing mitochondrial oxidative stress and vascular inflammation. Arterioscler. Thromb. Vasc. Biol. 33 (2013), 1928–1935.
41. [41] Xiong, S., Salazar, G., San Martin, A., Ahmad, M., Patrushev, N., Hilenski, L., et al. PGC-1 alpha serine 570 phosphorylation and GCN5-mediated acetylation by angiotensin II drive catalase down-regulation and vascular hypertrophy. J. Biol. Chem. 285 (2010), 2474–2487.
42. [42] Basso, N., Cini, R., Pietrelli, A., Ferder, L., Terragno, N.A., Inserra, F., Protective effect of long-term angiotensin II inhibition. Am. J. Physiol. Heart Circ. Physiol. 293 (2007), H1351–H1358.
43. [43] Michel, J.B., Heudes, D., Michel, O., Poitevin, P., Philippe, M., Scalbert, E., et al. Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries. Am. J. Phys. 267 (1994), R124–R135.
44. [44] Wang, M., Zhang, J., Jiang, L.Q., Spinetti, G., Pintus, G., Monticone, R., et al. Proinflammatory profile within the grossly normal aged human aortic wall. Hypertension 50 (2007), 219–227.
45. [45] Baker, D.J., Childs, B.G., Durik, M., Wijers, M.E., Sieben, C.J., Zhong, J., et al. Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 530 (2016), 184–189.